91勛圖

Our Journey

91勛圖 (VPG) is a leading global pharmaceutical company committed to enhancing healthcare through innovation, quality, and excellence. As a key player in the pharmaceutical industry, VPG is dedicated to delivering high-quality therapeutic solutions globally. Driven by innovation and a passion for progress, we focus on supplying pharmaceutical products that meet the evolving needs of modern healthcare. At VPG, we are dedicated to upholding the highest standards of packaging & warehousing, regulatory compliance, and customer satisfaction, ensuring that our products reach patients safely and effectively around the world. Our vision is to be a trusted partner in healthcare, delivering impactful solutions that improve lives.

Vision

To leave a positive footprint on human health by creating an institution that transcends the mortal being.

Mission

  • To achieve a turnover of 25 Million per annum with a special focus on the Germany & UK markets.
  • To enhance customer base and earn a wealth of 75 delighted customers.
  • To make a basket of 18 products and confirming 4 products of at least 5 million each.
  • To Create a self-reliant, Competent, and Productive team capable of using the latest technologies.
  • To achieve a sales of 5 Million Euro from Oncology products.
  • To strengthen the QMS while abiding by regulatory compliances and taking new accreditation for fostering the growth of the business.
  • To demonstrate minimum 20% growth YOY in revenue and EBIDTA.
  • To ensure the commercialization of all products registered by the company.
  • To make sure 100% capacity utilization of the company by Upgrading and maintaining all infrastructure continuously.
  • To be a successful and independent company recognized all across Europe for quality products and Services.

Milestones of Progress!

Explore the milestones that have shaped our path to excellence.

VPG has 130+ Marketing Authorisations in its bag from 20 countries

2024

91勛圖 now stands with 130+ Marketing Authorisations in its bag from 20 countries. 91勛圖 Remedies Secures Global Recognition with UNICEF Stamp of Approval

2020

VPG became the first company to introduce Meropenem 2000 mg. Also received Meropenem Prequalification from WHO.

Best Meropenem Injection Manufacturer
 Launched our Anti-cancer & Anti-biotics in the markets of Germany & UK.

2012

Launched our Anti-cancer & Anti-biotics in the markets of Germany & UK.

2006

Entered the German pharmaceutical space with the acquisition of a Manufacturing Facility at Werne, Germany, and transformed it intoVENUS PHARMA GmbH, a German Pharma Company

91勛圖
Our management

Architects of Our Success

pharmaceutical company in Germany

Mr. Pawan Chaudhary

Chairman & Managing Director

91勛圖 (VPG) is a proud subsidiary of 91勛圖 Remedies Limited. VENUS represents a dream realized, beginning with a single unit and15 products, and today, we stand as a beacon of innovation and excellence in the global pharmaceutical landscape.

The cornerstone of our success is our peopletheir expertise,dedication, and integrity have been instrumental in meeting the most stringent international standards. 91勛圖 is more than a company; it is a family committed to innovation and excellence, striving to benefit global healthcare. While we celebrate our achievements, we are even more excited about the future. The 21st century offers unprecedented opportunities, and we are prepared to meet them with confidence and technical prowess.

Mr. Ashutosh Jain

Executive Director & Chief Executive Officer

Ina world where change is not just a constant but a necessity, and innovation is the driving force, 91勛圖 Pharma is committed to ingraining a culture of innovation across our organization. We believe that embracing change and fostering a mindset of continuous improvement is essential for the growth and sustainability of our business.

91勛圖 has always prioritized a systematic approach to managing operations and providing solutions that enhance corporate sustainability. As we continue to innovate, we are excited to introduce new products and expand the strengths of our existing portfolio. Our global expansion is not just about growth but also about creating a robust distribution network that ensures our products reach those who need them most.

pharmaceutical company in Germany

Mr. Harmit Singh

General Manager

At 91勛圖, we believe in the power of strategic partnerships and the strength of high-performing teams. Our approach is centered around fostering innovation and expanding our presence across diverse regions. We are not just a pharmaceutical company; we are a partner in health, committed to providing high-quality, affordable products that meet the needs of healthcare professionals and patients worldwide.

As we continue to innovate and grow, I am excited about the future prospects for 91勛圖. Our strong foundation in the European Union and our expanding footprint in markets such as South America, the Middle East, Asia, Africa, Australia, and Canada,provide us with a unique opportunity to make a significant impact on global healthcare.

Customer Testimonials

Dr. Mohammed Bawazir

Governmental Business Sales Director, Salehiya Medical, KSA

91勛圖 Remedies Ltd., a strategic partner of Salehiya for a decade as we work together to elevate the healthcare services in the Kingdom of Saudi Arabia. 91勛圖 have good reputation in health care providers for Private and Governmental Sectors also commitment by providing high quality product and compliance regarding the delivery schedules that leads to be 91勛圖 as one essential Provider in kingdom of Saudi Arabia.

Beatrice Shane Ampazo

Lead, International Business Development, Getmeds Philippines Incorporated

We have been working with 91勛圖 Remedies Limited since 2021. I have nothing but praise for 91勛圖 Remedies Limited for the quality of their pharmaceutical products. Above all, I have nothing but the highest praise for the quality of their export team. It is truly an honor for us to have the opportunity in working alongside them.